RTW Biotech Opportunities (LON: RTW) net income
RTW Biotech Opportunities reported a net profit of $245.2m for fiscal 2025, 617.4% more than in fiscal 2024 ($34.2m).
Fiscal 2025 is the highest of the 5 fiscal years on record for RTW Biotech Opportunities. The biggest drop was in fiscal 2024, −58.9%. It reported a loss in 2 of those 5 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin |
|---|---|---|---|
| 2025 | $245.2m | +617.4% | — |
| 2024 | $34.2m | −58.9% | — |
| 2023 | $83.2m | — | — |
| 2022 | −$39.4m | — | — |
| 2021 | −$64.3m | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
RTW Biotech Opportunities net income compared with its sector
By net income for its latest fiscal year, RTW Biotech Opportunities ranks 82nd of the 136 Spanish and European financials companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 80th | Avanza Bank | SEK 2,609m | — |
| 81st | Peugeot Invest | €223.5m | — |
| 82nd | RTW Biotech Opportunities | $245.2m | — |
| 83rd | Coface | €222.0m | — |
| 84th | Gimv | €219.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in financials stocks.
Questions about the net income of RTW Biotech Opportunities
- How much did RTW Biotech Opportunities earn in fiscal 2025?
- RTW Biotech Opportunities reported a net profit of $245.2m for fiscal 2025. In fiscal 2024 it reported a net profit of $34.2m.
- What was the most profitable year for RTW Biotech Opportunities?
- Of its last 5 fiscal years, fiscal 2025, with $245.2m.
- Where does RTW Biotech Opportunities rank in its sector by net income?
- It ranks 82nd of the 136 Spanish and European financials companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for RTW Biotech Opportunities come from?
- From the report RTW Biotech Opportunities files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report RTW Biotech Opportunities files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on RTW Biotech Opportunities: the RTW Biotech Opportunities page · annual accounts.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.